CAFC to hear The Medicines Company v Hospira dispute en banc

16-11-2015

CAFC to hear The Medicines Company v Hospira dispute en banc

Kuzma / Shutterstock.com

The US Court of Appeals for the Federal Circuit will consider en banc whether a “supplier exception” should be included in laws that prevent the patenting of inventions that have already been on sale.


The Medicines Company; Hospira; US Court of Appeals for the Federal Circuit; Angiomax; bivalirudin; US FDA; ANDA; USPTO

LSIPR